COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 345.2 | 3 | 0097-0248 | 868.88 | 248.01 | 373 | 73.26 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 264.1 | 3 | 0098-0249 | 373.11 | 248.75 | 358 | 76.33 | 0.772 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 314.7 | 3 | 0099-0249 | 552.28 | 249.29 | 371 | 75.74 | 0.813 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 303.0 | 3 | 0100-0251 | 693.24 | 251.37 | 374 | 76.18 | 0.810 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1325.8 | 3 | 0101-0252 | 811.85 | 252.49 | 441 | 81.84 | 0.827 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 331.9 | 3 | 0102-0258 | 249.65 | 258.22 | 341 | 71.84 | 0.830 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 327.1 | 3 | 0103-0259 | 944.24 | 258.82 | 301 | 67.60 | 0.828 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 540.6 | 3 | 0104-0265 | 587.53 | 265.22 | 377 | 73.26 | 0.883 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 277.4 | 3 | 0105-0267 | 341.59 | 266.56 | 373 | 74.67 | 0.841 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 312.6 | 3 | 0106-0268 | 312.72 | 268.76 | 348 | 77.50 | 0.728 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 237.4 | 3 | 0107-0267 | 24.76 | 267.70 | 326 | 69.84 | 0.840 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 319.0 | 3 | 0108-0283 | 649.13 | 284.09 | 965 | 130.61 | 0.711 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 276.4 | 3 | 0109-0273 | 627.87 | 274.18 | 281 | 66.28 | 0.804 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 635.9 | 3 | 0110-0277 | 156.82 | 276.89 | 359 | 72.43 | 0.860 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 469.7 | 3 | 0111-0276 | 609.90 | 276.26 | 304 | 65.11 | 0.901 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 285.7 | 3 | 0112-0282 | 79.15 | 282.69 | 371 | 75.50 | 0.818 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 981.9 | 3 | 0113-0280 | 897.30 | 280.57 | 260 | 86.23 | 0.439 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 297.5 | 3 | 0114-0281 | 410.64 | 281.07 | 378 | 75.26 | 0.839 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 395.6 | 3 | 0115-0283 | 207.48 | 282.75 | 296 | 63.60 | 0.920 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 305.7 | 3 | 0116-0280 | 688.08 | 279.99 | 198 | 53.60 | 0.866 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1207.7 | 3 | 0117-0285 | 118.58 | 285.09 | 470 | 87.50 | 0.771 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 310.6 | 3 | 0118-0288 | 850.70 | 288.52 | 361 | 72.08 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 516.0 | 3 | 0119-0290 | 251.86 | 290.01 | 326 | 69.26 | 0.854 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 400.5 | 3 | 0120-0295 | 573.61 | 295.23 | 352 | 70.67 | 0.886 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 486.2 | 3 | 0121-0308 | 528.74 | 309.81 | 752 | 114.71 | 0.718 |